ArticleThe Journal of infectious diseases2025
Monkeypox Virus Transcriptional Profiles and Host Responses in Skin Lesion Swabs Among Individuals With Human Immunodeficiency Virus.
Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The impact of HIV coinfection on mpox patients: a systematic review and meta-analysis.Emerging microbes & infections · 2026Pooled it
- The impact of human immunodeficiency virus coinfection on mpox patients during the 2022 global outbreak: a systematic review and meta-analysis based on comparative observational studies.Frontiers in microbiology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundMpox disease, caused by the monkeypox virus (MPXV), remains a global health concern with nearly half of all cases occurring among individuals with human immunodeficiency virus (HIV). While recent studies have advanced our understanding of poxvirus pathogenesis, the molecular effects of mpox and HIV coinfection are still poorly understood. This study uses dual RNA sequencing (RNA-seq) to characterize host and viral gene expression in skin lesion swabs from people with mpox, including individuals with and without HIV.
methodsOur cohort included 19 participants with confirmed MPXV infection, with 53 total skin lesion swabs collected during the early (7-13 days post-symptom onset) and late (15-21 days post-symptom onset) stages of mpox disease. RNA-seq was used to assess both host and MPXV gene expression over time in participants with and without HIV.
resultsHIV-positive participants showed upregulation of MPXV genes involved in immune evasion and viral replication. Conversely, host immune pathways, such as interferon signaling, apoptosis, and chemokine recruitment, were downregulated in participants with HIV. Pathway enrichment analysis revealed dysregulated immune signaling and autophagy, key processes for viral clearance. These findings suggest that HIV-related immunosuppression may enhance MPXV replication and prolong disease.
conclusionsThis study highlights the use of dual RNA-seq in uncovering molecular interactions between host and virus during mpox infections. Our findings offer insights into how HIV coinfection may alter MPXV pathogenesis, with implications for treatment strategies and disease management in immunocompromised populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.